SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001422848-16-000257
Filing Date
2016-02-16
Accepted
2016-02-12 17:36:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A edgkite.txt SC 13G/A 7658
  Complete submission text file 0001422848-16-000257.txt   9152
Mailing Address 333 SOUTH HOPE STREET 55TH FLOOR LOS ANGELES CA 90071
Business Address 333 SOUTH HOPE STREET 55TH FLOOR LOS ANGELES CA 90071 213-486-9200
Capital Research Global Investors (Filed by) CIK: 0001422848 (see all company filings)

IRS No.: 951411037 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G/A

Mailing Address 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address 2225 COLORADO AVENUE SANTA MONICA CA 90404 (310) 824-9999
Kite Pharma, Inc. (Subject) CIK: 0001510580 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A | Act: 34 | File No.: 005-88615 | Film No.: 161421250
SIC: 2836 Biological Products, (No Diagnostic Substances)